$1.58
7.06%
Nasdaq, Fri, Nov 15 2024
ISIN
US34385P1084
Symbol
FLDM

Fluidigm Corporation Stock price

$1.58
-0.31 16.40% 1M
-0.95 37.55% 6M
-0.63 28.51% YTD
-0.62 28.18% 1Y
-3.18 66.81% 3Y
-0.93 37.05% 5Y
-28.43 94.74% 10Y
Nasdaq, Closing price Fri, Nov 15 2024
-0.12 7.06%
ISIN
US34385P1084
Symbol
FLDM
Sector

Key metrics

Market capitalization $588.17m
Enterprise Value $311.31m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.00
P/S ratio (TTM) P/S ratio 3.77
P/B ratio (TTM) P/B ratio 1.20
Revenue growth (TTM) Revenue growth 48.23%
Revenue (TTM) Revenue $155.90m
EBIT (operating result TTM) EBIT $-119.93m
Free Cash Flow (TTM) Free Cash Flow $-148.51m
Cash position $366.33m
EPS (TTM) EPS $-0.71
P/E forward negative
P/S forward 3.70
EV/Sales forward 2.08
Short interest 8.46%
Show more

Is Fluidigm Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

Fluidigm Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Fluidigm Corporation forecast:

3x Buy
100%

Analyst Opinions

3 Analysts have issued a Fluidigm Corporation forecast:

Buy
100%

Financial data from Fluidigm Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
156 156
48% 48%
100%
- Direct Costs 80 80
40% 40%
51%
76 76
58% 58%
49%
- Selling and Administrative Expenses 124 124
62% 62%
79%
- Research and Development Expense 55 55
102% 102%
35%
-103 -103
86% 86%
-66%
- Depreciation and Amortization 17 17
13% 13%
11%
EBIT (Operating Income) EBIT -120 -120
70% 70%
-77%
Net Profit -125 -125
65% 65%
-80%

In millions USD.

Don't miss a Thing! We will send you all news about Fluidigm Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Fluidigm Corp. is engaged in the development, manufacture and marketing of biotechnology tools fro life sciences research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics; and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen R. Quake and Gajus V. Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.

Head office United States
CEO Michael Egholm
Employees 539
Founded 1999
Website www.standardbio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today